How long can you leave between Mounjaro doses — and what happens if the gap changes?

You've realised it's been more than a week, here's the shape of the decision

Picture this: it's Sunday evening and you notice the pen still in the fridge door, untouched. Your usual injection day was Wednesday. That's four days late, which puts you in different territory from a dose that's only a day or two overdue. The Mounjaro Patient Information Leaflet (the document that governs how the medicine is used in the UK) sets out a straightforward framework. If fewer than five days have passed since the dose was due, take it as soon as you remember and then continue on your original weekly day going forward. If five or more days have passed, the guidance is to skip that dose entirely and resume on the next scheduled date.

One thing worth letting go: the idea that taking a late dose sooner rather than later always means double benefit. Tirzepatide doesn't work that way. Its effect builds steadily over weeks of consistent exposure; a single bridging injection won't accelerate results, and stacking doses too close together raises the chance of gastrointestinal side effects. The NHS medicines page for tirzepatide reinforces that the seven-day gap exists for tolerability as much as efficacy.

If you are unsure which category your situation falls into, or if missed doses are becoming a pattern, that is exactly the kind of question the team at nume's aftercare support is available seven days a week to help with. Your prescriber can review your schedule without you needing to start over.

Why the interval matters more at some doses than others

Early in treatment (at 2.5mg) the interval feels almost academic because that first strength is primarily a tolerability measure. Your system is adapting to a new mechanism rather than experiencing the medicine's full therapeutic effect. Consistency still helps, but missing a day or two is unlikely to produce dramatic changes in how you feel. If you want to understand what the 2.5mg dose is actually doing during that opening phase, the detail is worth reading.

At higher strengths (7.5mg, 10mg, 12.5mg, 15mg) the weekly rhythm carries more weight. Your body has adapted to a steady drug level, and a significant gap can disrupt that equilibrium. Some people notice their appetite returning more sharply in the days before their next scheduled injection anyway; a prolonged gap amplifies that. There is also a titration consideration: if a very long gap occurs at a higher dose, a prescriber may want to step the dose back temporarily before resuming, to avoid tolerability problems. That decision is not something to make independently. The 5mg dose page has more on how each step change works in practice.

For a broader sense of how doses relate to one another during titration, the comparison of 2.5mg and 5mg covers the practical differences in effect and adjustment period.

Practical questions about scheduling: adjusting your injection day

Life doesn't always cooperate with a fixed weekly day. Holidays, shift patterns, a procedure that needs you nil-by-mouth, all of them can push or pull at the schedule. The good news is that moving your injection day is possible, with some care. If you want to shift earlier in the week, you can take your next dose after a minimum of four days from the previous one, and if you want to understand how long between Mounjaro doses is safe when you are adjusting your schedule, that page sets out the boundaries clearly. If you want to move later, simply wait to the new day and carry on from there. Both options are described in the BNF tirzepatide entry, which is the reference UK prescribers use.

Adjusting once is different from adjusting repeatedly. If your injection day keeps moving around, you lose the consistency the schedule depends on, and the cumulative effect of irregular intervals can affect both tolerability and the slow, steady results the medicine is designed to produce. Picking a day that genuinely suits your week (one with no regular commitments that might interrupt the routine) makes more difference than most people expect. The pen in the fridge door, same day every week, is the practical target.

Questions about how long a missed dose can safely be left come up regularly, and the answer depends on where in the five-day window you sit. The fuller detail is worth reading if you are weighing up whether to take a late dose or skip it. Cost and supply considerations sometimes play into the decision too, recent changes to Mounjaro's UK pricing have prompted questions about whether people are stretching doses to manage costs, which is not something the prescribing schedule supports.

When a gap means checking in with your prescriber rather than self-managing

Most single missed doses resolve straightforwardly by following the Patient Information Leaflet. But there are situations where checking with your prescriber is the right call rather than working through the decision alone. If you have missed several doses in a row (perhaps during a hospital stay, a period of illness, or because supply was disrupted) resuming at the same strength you left off is not automatically safe. A prescriber can assess whether a temporary step-down makes sense.

Similarly, if you are in the middle of a dose titration and a long gap occurs right around the time you were due to move to the next strength, the question of whether to proceed with the increase or hold becomes a clinical one. Pushing ahead without that check-in can expose you to a rougher adjustment than necessary.

Reporting any unusual symptoms after a resumed dose is also wise. The MHRA's Yellow Card scheme exists for exactly this kind of experience, you can log anything unexpected and contribute to the ongoing safety monitoring that all medicines under the Black Triangle designation receive. Mounjaro carries that designation in the UK, meaning post-market surveillance is active and your report counts.

If you are working out what treatment looks like for you from the beginning, the free consultation at nume is reviewed the same day by a real prescriber (not software) and is a good place to start that conversation.